MedPath

Pitocin

Pitocin (Oxytocin Injection, USP) Synthetic

Approved
Approval ID

6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 12, 2020

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

oxytocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42023-130
Application NumberNDA018261
Product Classification
M
Marketing Category
C73594
G
Generic Name
oxytocin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 9, 2020
FDA Product Classification

INGREDIENTS (3)

OXYTOCINActive
Quantity: 10 [iU] in 1 mL
Code: 1JQS135EYN
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
CHLOROBUTANOLInactive
Code: HM4YQM8WRC
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pitocin - FDA Drug Approval Details